Rescue of TRAF3-null Mice by P100 NF-kappa B Deficiency
Overview
General Medicine
Authors
Affiliations
Proper activation of nuclear factor (NF)-kappaB transcription factors is critical in regulating fundamental biological processes such as cell survival and proliferation, as well as in inflammatory and immune responses. Recently, the NF-kappaB signaling pathways have been categorized into the canonical pathway, which results in the nuclear translocation of NF-kappaB complexes containing p50, and the noncanonical pathway, which involves the induced processing of p100 to p52 and the formation of NF-kappaB complexes containing p52 (Bonizzi, G., and M. Karin. 2004. Trends Immunol. 25:280-288). We demonstrate that loss of tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) results in constitutive noncanonical NF-kappaB activity. Importantly, TRAF3-/- B cells show ligand-independent up-regulation of intracellular adhesion molecule 1 and protection from spontaneous apoptosis during in vitro culture. In addition, we demonstrate that loss of TRAF3 results in profound accumulation of NF-kappaB-inducing kinase in TRAF3-/- cells. Finally, we show that the early postnatal lethality observed in TRAF3-deficient mice is rescued by compound loss of the noncanonical NF-kappaB p100 gene. Thus, these genetic data clearly demonstrate that TRAF3 is a critical negative modulator of the noncanonical NF-kappaB pathway and that constitutive activation of the noncanonical NF-kappaB pathway causes the lethal phenotype of TRAF3-deficient mice.
Jung D, Seo M, Jo J, Kim K, Kim C, Kang H NPJ Precis Oncol. 2024; 8(1):170.
PMID: 39090283 PMC: 11294552. DOI: 10.1038/s41698-024-00654-2.
Wang P, Liu Z, Sweef O, Saeed A, Kluz T, Costa M Cancer Lett. 2024; 589:216827.
PMID: 38527692 PMC: 11375691. DOI: 10.1016/j.canlet.2024.216827.
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.
Amjad E, Pezzani R, Sokouti B Oncol Res. 2024; 32(3):439-461.
PMID: 38361756 PMC: 10865741. DOI: 10.32604/or.2023.044473.
Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3.
Cai M, Peng H, Liu M, Huang M, Zheng W, Zhang G Int J Nanomedicine. 2023; 18:7065-7077.
PMID: 38046234 PMC: 10693246. DOI: 10.2147/IJN.S438229.
Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
Boyce B, Li J, Yao Z, Xing L Endocrinol Metab (Seoul). 2023; 38(5):504-521.
PMID: 37749800 PMC: 10613774. DOI: 10.3803/EnM.2023.501.